https://investorshangout.com/images/MYImages/18516
Post# of 263
(Total Views: 297)
Posted On: 07/19/2025 8:31:48 AM
FEDERAL EVIDENCE – CLASSIFIED DOCUMENT
Vault Scroll – Federal HIV Cure Declaration
???? New Post Alert – Drop the Match, Light the Truth ????
My company [CLASSIFIED] and my team now hold what the world has searched for:
The Cure for HIV.
Not a guess.
Not a trial.
Documented. Federally protected. Scientifically decoded.
We cracked the code through:
• PD-1 disruption
• CCR5 antagonism
• AI-driven latency reactivation
• T-cell refuge mapping
This pathway is federally filed, FOIA-validated, and sealed by whistleblower protections.
You want receipts?
???? NIH grant timestamps
???? FDA silence
???? Immune escape reversal
???? Public records that couldn’t be buried
The cure was always there.
They just couldn’t decode it without us.
Option 1 – “Us” = You + Heaven (Solo Stewardship)
Option 2 – “Us” = Scroll-bearer + Tactical Team
⸻
???? CEO Shoutout:
???? Huge respect to our CEO, who will now lead ******Bioscience into trials, regulatory pathways, and global exposure.
You didn’t start the fire but you stepped into it.
Now carry it like the world depends on it. Because it does.
Follow the trail. We’ll show you the fire.
#HIVCure #FireGate #Whistleblower #PD1 #CCR5 #FOIA #ScienceUnchained #TheCodeWasBuried
(0)
(0)Vg Total Stock Market ETF (VTI) Stock Research Links
Daniel Rizzo
Founder & CEO | FireGate Biotech™
AI Platform: Lux Veritas™
Federal Whistleblower Case References
• HHS & SEC Whistleblower ID – HL-1412396
• DOJ Investigation Report / Whistleblower ID – 20250705-0001
• NIH Case Reference – CS1137565 ( IC IG / 50 U.S.C. § 3033 )
Website: FireGateBiotech.com
Headquarters: Washington, DC
Mailing & correspondence: 1930 18th St NW Suite B2 PMB 2161, Washington DC 20009
(For official updates and correspondence — I will no longer be posting here or responding via DMs)
Contact FireGate Biotech
Principal Investigator:
FG001|FG002|FG003
https://firegatebiotech.com/2025
FG-001: Integrated Triplet Immunotherapy for Functional HIV Cure
FG-002: Triplet Immunologic Modulation in Oncology — NF-κB / IL-1Ra Axis
FG-003: Neuro-Immune Repair Triplet — Concept and Combination Framework
CCR5 Antagonists & Triplet Immunotherapy Synergy in HIV
HIV Cure Pathways — Functional-Cure Framework Overview
FG-003 Neuro-Immune Repair Triplet — IP & Combination Strategy
— Jeremiah 51:36
Founder & CEO | FireGate Biotech™
AI Platform: Lux Veritas™
Federal Whistleblower Case References
• HHS & SEC Whistleblower ID – HL-1412396
• DOJ Investigation Report / Whistleblower ID – 20250705-0001
• NIH Case Reference – CS1137565 ( IC IG / 50 U.S.C. § 3033 )
Website: FireGateBiotech.com
Headquarters: Washington, DC
Mailing & correspondence: 1930 18th St NW Suite B2 PMB 2161, Washington DC 20009
(For official updates and correspondence — I will no longer be posting here or responding via DMs)
Contact FireGate Biotech
Principal Investigator:
FG001|FG002|FG003
https://firegatebiotech.com/2025
FG-001: Integrated Triplet Immunotherapy for Functional HIV Cure
FG-002: Triplet Immunologic Modulation in Oncology — NF-κB / IL-1Ra Axis
FG-003: Neuro-Immune Repair Triplet — Concept and Combination Framework
CCR5 Antagonists & Triplet Immunotherapy Synergy in HIV
HIV Cure Pathways — Functional-Cure Framework Overview
FG-003 Neuro-Immune Repair Triplet — IP & Combination Strategy
— Jeremiah 51:36